HDAC6 and neoplasm: Moreover, the phenotypic responses associated with ricolinostat in tumours have been reported at concentrations higher than the HDAC6-selective concentrations in which the reported toxicity of IC50 doses were found to be high enough to inhibit nuclear HDACs [96].